Previous issue | Volume 98 | ESPE2024

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

Card image cap
The 62nd ESPE Annual Meeting will now be taking place in Liverpool, UK.

Symposia

Novel Advances in the Treatment of Hypothalamic disease

hrp0098s3.2 | Novel Advances in the Treatment of Hypothalamic disease | ESPE2024

Use of MC4R agonist in hypothalamic obesity

Argente Jesús

Clinical and experimental evidence supports the important contribution of brain circuits in the pathogenesis of obesity. While functional perturbation of hypothalamic pathways could underlie common forms of obesity, the term “hypothalamic obesity” has been coined to define rare forms of severe overweight where a clear hypothalamic substrate, either genetic or acquired, can be identified. Addressing the problem of early-onset, severe obesity in children is of utmost...